Results 81 to 90 of about 12,163 (174)
Edoxaban (Lixiana®) [díptic]
, 2018 Anticoagulants orals d’acció directa; Edoxaban; MedicamentsAnticoagulantes orales de acción directa; Edoxaban; MedicamentosDirect-acting oral anticoagulants; Edoxaban; MedicinesPreguntes i respostes sobre l’anticoagulant oral d’acció directa, Edoxaban ...core In vitro assessment of edoxaban anticoagulant effect in pediatric plasma
, 2019 Epub ahead of printINTRODUCTION: Anticoagulant therapy in pediatric patients remains an issue and safer therapies, such as direct oral anticoagulants could overcome the limitations of conventional anticoagulant treatments in this population.Sinegre, Thomas, Pereira, B., Greze, V., Zlobecki, M., Lebreton, A. +4 morecore +1 more sourcePostmarketing safety experience with edoxaban in Japan for thromboprophylaxis following major orthopedic surgery
, 2013 Yasufumi Kuroda,1 Chie Hirayama,2 Hitoshi Hotoda,2 Yasuhiro Nishikawa,2 Akinori Nishiwaki21Daiichi Sankyo Pharma Development, Edison, NJ, USA; 2Daiichi Sankyo Company, Limited, Tokyo, JapanPurpose: Edoxaban is an oral, once-daily, selective, direct ...Hotoda H, Kuroda Y, Nishikawa Y, Nishiwaki A, Hirayama C +4 morecore Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. [PDF]
, 2013 International audienceBACKGROUND: Whether the oral factor Xa inhibitor edoxaban can be an alternative to warfarin in patients with venous thromboembolism is unclear.Matoska P, Segers A., Grosso, Michael A., Gerrits P, Grosso, MA, Prins M. H., Tomkowski W, Grossman E, Shi, Minggao, Oliven A, Ashkenazy B, Torp Pedersen C, Franc J, Agnelli G, Angchaisuksiri P, Sacilotto R, Galindo J, Wang XX, Espinola Klein C, Verhamme, P, Guenneguez H, Razso K, Fletcher J, Weltermann A, Nunohiro T, Tian HY, Cavalcanti M, Zhao JC, Taniguchi S, Vitovec M, Wang YQ, Blombery P, Yeganeh S, Timi JM, Shafai Sarshar R, Breuil N, Langner A, Prins, M.H., Higareda I, Landi A, Carrier M, Shivakumar S, Harper P, Urbanova R, Verhamme P, Yu J, Schellong, Sebastian M., Galanaud JP, Öngen G, Schwocho L, Zhang JW, Gasztonyi B, Rifaï A, Meriste S, Hao QL, Schellong, Sebastian M, Sandset PM, Brønnum Schou J, Gerdes VE, Middeldorp S., Dominguez H, Duchateau J, Aleil B, Eischer L, Roberts R, Sun SB, Agarwal S, Chechulov P, Wells P, Diaz Castañon J, Yasuda C, Chiche O, Durairaj N, Goldstein L, Middeldorp, S., Rao B, Kim SH, Oh DY, Jerjes Sanchez C, Kamphuisen PW, Jindal R, Roy PM, Ghirarduzzi A, Liu CJ, Nakamura M, Peerlinck K, Kulkarni R, Poulsen SH, Blüguermann J, Décousus, H., Bauersachs R, Otten HM, Crowther M, Liu CW, Trinh Duc A, Eriksson H, Dees A, Chlumský Y, Verstraeten P, Paumets M, Szigyártó M, Andersen B, Roecken M, Kurimoto T, Chlumsky J, Ma Z, Liu S, Wells, Phil, Vishram J, Wautrecht JC, Imbert B, Mercuri M, Chen RC, Dani V, Balaji R, Décousus, Hervé, Jie KS, Raskob, Gary E., Beyer Westendorf J, Pavic M, Kroening R, Tzoran I, Brandjes D, Ghaisas N, Baghestanian M, De Maistre E, Ageno W, Iwata H, Annichino Bizzacchi JM, Sipos G, Mello TB, Chang HJ, Marschang P, Verhamme P., Lovelace G, Anderson D, Barillari G, Banker D, Desai SC, Sanchez O, Piovella F, Meneveau N, Accassat S, Srinivas A, Raskob G, Motte S, Aquilanti S, Rai K, Mercuri, M, Pecsvarady Z, Dayasagar Rao V, Brighton T, Nishigami K, von Bilderling P, Heng LL, Kamerkar D, Oudeman L, van Bergen P, Brisot D, Nishi Y, Fujimoto K, Griffioen A, Lanz H, SIRAGUSA, Sergio, Rho BH, Brenner B, Lyons R, Verhamme, P., Gong XW, Arneja J, Frommhold R, Bortoluzzi C, Franke D, Desai P, Mo M, Holub M, Manenti E, Ferrari E, Ryba M, Eerenberg ES, Vanassche T, Schellong SM, Farkas K, Ceressetto J, Halbritter K, De Vleeschauwer P, Mercuri M., Traby L, El Kouri D, Caraco Y, Yoshida H, Hrabar, Decousus H, Middeldorp, S, Rehm J, Shi, M., Correa de Carvalho F, Kamphuisen, P.W., Vandekerkhof J, Brans E, Scarvelis D, Ye XF, Mahe I, Choi WI, Tran H, Sebő N, van Bellen B, Brodmann M, Lang P, Yanushko V, Kobayashi T, Mody B, Mottier D, Schmidt J, Boda Z, Kim KU, Hes R, Kwon KY, Erdkamp F, Kim JY, Pawar N, Aoyama T, Beenen L, Singh R, Couturaud F, Pandharpurkar HK, Saravanan S, Sokurenko G, Nyirati G, Buller H. R., Macin S, Quintavalla R, MacGillavry M, Gomez Lara J, Wiewel Verschueren S, Falanga A, Davidson B, VanSpronsen H, Prins, Martin H., Hurley S, Baker RI, Lim SY, Brousse C, Ward C, Büller, H.R., Buchmuller A, Fijnheer R, Pinjala R, Shi ZY, Flota LF, Shimizu K, Doyen D, Grosso M, Kovacs M, Davidovskaya E, Kadarik M, Lorcerie B, Kim HS, Kovacs A, Gavish D, Smith M, Penurkar M, Horacek T, Quere I, Vinod M, Bhonagiri S, Roithinger F, Mayer O, Chandrashekar AR, Eikelboom J, Tupa M, Zimlichman R, Pomper L, Pilger E, Mirea C, Raidjuk L, Stephan D, Patel J, Patel K, Jain R, Frankfurter Z, Clairand R, Ostergaard O, Mottier, Dominique, Skinner M, Yamada N, Simoneau G, Qin XJ, Leroux L, ten Wolde M, Oberti P, Gorokhovsky S, Schwocho, Lee, Lin M, Asferg C, Nagabhushan KN, Patek F, Grange C, Cattaneo M, Akita T, Joh JH, Bai CX, Munemasa M, Satoh T, Slagboom T, Qin ZQ, de la Fuentes P, Diehm C, Braester A, Monreal M, Zhao J, Lee TS, Babhulkar S, Riba M, Kim DJ, Mismetti P, Gupta S, Mercuri, Michele, Palomar Lever A, Banyai M, Cohen A, Hong YS, Laheäär M, Weitz J, Bueller, Harry R., Suresh KR, Ying KJ, Stellbrink C, Mehta P, Gudz I, Kahrmann G, Peters F, Cheng ZZ, Kwon TW, Décousus, H, Podoubský R, Maeda H, Peters R, Dharmadhikari A, Ravi Kishore AG, Karovitch A, Bhagavan NK, Raskob, G.E., Ma GF, Meyer G, Kaplowitz N, Haugaard Nielsen B, Hirmerova J, Weisser G, Serisier DJ, Segers A, Prins, MH, Ikeda U, Pessayre D, Yoon HI, Pernod G, Decousus H., Schwocho, L., Büller, Harry R., Crestani B, Mercuri, M., Büller, Harry R, Grover T, Amuchastegui LM, Jiang L, Park KH, Roos Y, Lacroix P, Jeppesen J, Mahuad C, Gallant B, Iosub DI, Satokawa H, Kovarova K, Murakami H, Spacek R, Desormais I, Kulik A, Nielsen H, Suzuki Y, Klucsik Z, Cassettari A, Bernhard S, Gurzó M, Swart Heikens J, Schellong S, Yanushka A, Montaclair K, Grosso, M.A., Kahn SR, Debaveye B, Achkar A, Adzerikho I, Hanzawa K, Grosso M. A., Alvarez C, Hainaut P, Burihan M, Olah Z, Lacut K, Barrier R, van Es J, Hu XY, Tsujita K, Shiroma H, Jeppesen, Jørgen Lykke, Zhang G, Jacobson B, Shi M., Shi M, van Kranen R, Zhang J, Ilonczai P, Kolossváry E, Middeldorp S, Zhang L, Zhang S, Atalay S, Toth K, Merriman E, Ritchie B, Yuan YD, Crispin P, Chan N, Elias A, Martin M, Gallus A, Shetty P, Vandenbriele C, Verhamme, Peter, Yin WH, Du YC, Hola D, Chong B, Zeltser D, Elias M, Stafford L, Meijer K, Heuer H, Blazejova S, Segers, A., Nishibe T, Kooistra H, Crerand W, Sevestre MA, Cukier A, Kappelhoff J, Hutyra M, Varga C, Correa J, Egstrup K, Diamand JM, Dudhagra N, Manenti ER, Lishner M, Obayashi T, Raskob G. E., Raskob, Gary E, Middeldorp, Saskia, Yang YH, Ockelford P, Rachmilevitz R, Prins, Martin H, Deshpande A, Pasca S, Auscher S, Lugassy G, Gu YQ, Schellong, S.M., Bredie SJ, Kuang TG, Mehta A, Porreca E, Kondo K, Giordano C, Michaelsen M, Wang C, Wu Q, Investigators, Hokusai-VTE, Mathies R, Yun WS, Betcher J, Santini F, Schwocho, L, Kumar S, Büller H, Klimsa Z, Castañon JD, Siragusa S, Wang Y, Wen FQ, Schlammadinger A, Debing E, Huang B, Chakra M, Voigts B, Yang H, Kothurkar A, Kyrle PA, Sumanthraj K, Maslianski B, Sámson Z, Berthier S, Köhler C, Bounameaux H, Carroll P, lahav M, Coughlin P, Schellong S. M., Boersma WG, Segers, Annelise, Kothiwale VA, Shi, M, Menezes FH, Rodriguez D, Mun YC, Prins M, Zhang FX, Kim YK, Lodigiani C, Ten Cate H, Girija KR, Schwocho L., Joshi S, Schellong, SM, Masik S, Minar E, Segers, A, Szabó I, Robinson K, Raval A, Parakh R, Grosso, Michael A, Büller, HR, Szabó T, Raval M, Choi JS, Sonoda M, Raskob, GE, Lawall H, Oh D, Wells, P., Galsgaard I, de Graaff CS, Gustin M, Picchi C, Szigeti S, Werth S, Beyer-Westendorf J, Torp-Pedersen C, Espinola-Klein C, Jerjes-Sanchez C, Haugaard-Nielsen B, Prandoni P, Wells, Diaz-Castañon J, Trinh-Duc A, Brønnum-Schou J, Palomar-Lever A, Shafai-Sarshar R, PhilpBüller H, Annichino-Bizzacchi JM +561 morecore +1 more sourceSustained safe and effective anticoagulation using Edoxaban via percutaneous endoscopic gastrostomy
ESC Heart Failure, 2019 Extensive data support the safety of direct oral anticoagulants compared with vitamin K antagonists in patients with non‐valvular atrial fibrillation, leading to a significantly increase in the use of these compounds in clinical practice.Mattia Galli, Domenico D'Amario, Felicita Andreotti, Italo Porto, Rocco Vergallo, Mario Sabatelli, Stefano Lancellotti, Emiliana Meleo, Raimondo De Cristofaro, Filippo Crea +9 moredoaj +1 more sourceEdoxaban versus warfarin in patients with atrial fibrillation
, 2022 BACKGROUND: Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known.R Corbalán (13416618), A Parkhomenko (13317888), C Otto (6973043), K Bauer (9877379), E Paolasso (13445037), H Lanz (13554574), W Ruzyllo (13539103), S E Morin (13554565), H Heidbuchel (7937384), C Hassager (13344537), M Ruda (13416654), J L Halperin (13444986), R Botero (13416621), J D Easton (13554688), M Ostojic (13554664), M Horna (13554661), J J Hanyok (13554550), M Bergovec (13554616), G Sotomora (13554643), J Davé (13554583), M Dorobantu (11277381), A Dalby (13554670), P Sritara (13533001), J Y LeHeuzey (13554634), J Kappelhof (13554589), I Patel (7782545), D Atar (13344240), S Juul-Möller (13554676), M Mercuri (13554553), J I Weitz (13554532), Y Koretsune (13554538), A Duggal (13554580), J Morais (11347308), T Ophuis (13554658), E M Antman (13554556), T Yamashita (4487413), J Xie (9877934), A Skene (13554685), W Crerand (13554586), D Alexopoulos (13554640), A García-Castillo (13554655), S P Patel (13554547), N Chung (13339518), S A Murphy (13409679), J J Blanc (13554631), V Curt (13554577), Y Yang (6099497), H White (7749056), E B Hoffman (13554568), E Braunwald (13554526), R Kiss (13554646), G Selicato (13554595), T Moccetti (13416492), R P Giugliano (13409706), M Nieminen (13554628), H Huikuri (13554625), S D Wiviott (13416144), P Grande (13554619), J Voitk (13554622), Y Malynovsky (13554562), K Smith (7711202), S A Chen (13444998), J Špinar (13554535), W Maxwell (13554592), J Camm (13553476), M Shi (12793552), R Senior (13554679), C Lowe (9866735), J Betcher (13554541), D Roy (13445976), C T Ruff (13554523), L Peruzzotti-Jametti (13554559), N Babilonia (13416648), A Goudev (13554613), N Deenadayalu (13554571), P Merlini (13554652), A L Waldo (13554529), B Lewis (7802297), P Aylward (13554610), J Anderson (9890636), J L Zamorano (13554673), V Mitrovic (13554637), M D Ezekowitz (13415169), Y Choi (11075004), J Jin (6951431), J Ostroske (13554601), L T Grip (13554544), M Skinner (13279530), T Duris (13554667), F Verheugt (13554682), A Oto (13539133), M Metra (7731092), C Reissner (13554598), B SomaRaju (13554649), S Connolly (13554607), D Morgan (11498719), J C Nicolau (13416606), A Ron (13554604), S Goto (13416639) +98 morecore Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016 BackgroundWe studied the concomitant use of single antiplatelet therapy (SAPT) on the efficacy and safety of the anti‐Xa agent edoxaban in patients with atrial fibrillation (AF). Methods and ResultsENGAGE AF‐TIMI 48 was a randomized trial that compared 2 Haiyan Xu, Christian T. Ruff, Robert P. Giugliano, Sabina A. Murphy, Francesco Nordio, Indravadan Patel, Minggao Shi, Michele Mercuri, Elliott M. Antman, Eugene Braunwald +9 moredoaj +1 more sourceEfficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016 BackgroundElderly patients with atrial fibrillation are at higher risk of both ischemic and bleeding events compared to younger patients. In a prespecified analysis from the ENGAGE AF‐TIMI 48 trial, we evaluate clinical outcomes with edoxaban versus ...Eri Toda Kato, Robert P. Giugliano, Christian T. Ruff, Yukihiro Koretsune, Takeshi Yamashita, Robert Gabor Kiss, Francesco Nordio, Sabina A. Murphy, Tetsuya Kimura, James Jin, Hans Lanz, Michele Mercuri, Eugene Braunwald, Elliott M. Antman +13 moredoaj +1 more source
